Advertisement

Aesthetic Plastic Surgery

, Volume 43, Issue 5, pp 1408–1409 | Cite as

Letter to the Editor on Managing Pathologic Scars by Injecting Auto-Cross-Linked Hyaluronic Acid: A Preliminary Prospective Clinical Study

  • Zi-Li Sun
  • Yi Feng
  • Feng-Lai YuanEmail author
  • Guo-Zhong LvEmail author
Letter to the Editor
  • 75 Downloads

Notes

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflicts of interest to disclose.

Human and Animal Rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

For this type of study, informed consent is not required.

References

  1. 1.
    Riccio M et al (2019) Managing pathologic scars by injecting auto-cross-linked hyaluronic acid: a preliminary prospective clinical study. Aesthetic Plast Surg 43(2):480–489CrossRefPubMedGoogle Scholar
  2. 2.
    van de Kar AL et al (2005) Reliable and feasible evaluation of linear scars by the Patient and Observer Scar Assessment Scale. Plast Reconstr Surg 116(2):514–522CrossRefPubMedGoogle Scholar
  3. 3.
    Guix B et al (2001) Treatment of keloids by high-dose-rate brachytherapy: a seven-year study. Int J Radiat Oncol Biol Phys 50(1):167–172CrossRefPubMedGoogle Scholar
  4. 4.
    Berman B, Maderal A, Raphael B (2017) Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg 43(Suppl 1):S3–S18CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery 2019

Authors and Affiliations

  1. 1.Wuxi Clinical Medicine School of Integrated Chinese and Western MedicineNanjing University of Chinese MedicineWuxiChina
  2. 2.Department of Pharmacology, Medical SchoolYangzhou UniversityYangzhouChina
  3. 3.Department of Orthopaedics and Central LaboratoryThe Third Hospital Affiliated to Nantong UniversityWuxiChina

Personalised recommendations